NasdaqGS:BNTXBiotechs
Is BioNTech (BNTX) Pricing Reflecting Its Mixed Returns And Conflicting Valuation Signals?
If you are wondering whether BioNTech is currently priced attractively or not, the key question is whether the market is fairly reflecting the company’s long term prospects in its share price.
The stock recently closed at US$106.62, with a 6.3% decline over the last 7 days, a 6.5% gain over the last 30 days and a 10.3% return year to date, while the 1 year, 3 year and 5 year returns stand at a 9.3% decline, 24.7% decline and 8.4% decline respectively.
These mixed returns sit against a...